197 related articles for article (PubMed ID: 21664218)
1. Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion.
Embry A; Meng X; Cantwell A; Dube PH; Xiang Y
Vaccine; 2011 Jul; 29(33):5331-9. PubMed ID: 21664218
[TBL] [Abstract][Full Text] [Related]
2. A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.
Galen JE; Wang JY; Carrasco JA; Lloyd SA; Mellado-Sanchez G; Diaz-McNair J; Franco O; Buskirk AD; Nataro JP; Pasetti MF
Infect Immun; 2015 Jan; 83(1):161-72. PubMed ID: 25332120
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
[TBL] [Abstract][Full Text] [Related]
4. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
Sun W; Sanapala S; Henderson JC; Sam S; Olinzock J; Trent MS; Curtiss R
Infect Immun; 2014 Oct; 82(10):4390-404. PubMed ID: 25114109
[TBL] [Abstract][Full Text] [Related]
5. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
Branger CG; Fetherston JD; Perry RD; Curtiss R
Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
[TBL] [Abstract][Full Text] [Related]
6. A Recombinant Attenuated
Singh AK; Curtiss R; Sun W
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.
Branger CG; Sun W; Torres-Escobar A; Perry R; Roland KL; Fetherston J; Curtiss R
Vaccine; 2010 Dec; 29(2):274-82. PubMed ID: 20979987
[TBL] [Abstract][Full Text] [Related]
8. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.
Miller NC; Quenee LE; Elli D; Ciletti NA; Schneewind O
Infect Immun; 2012 Apr; 80(4):1572-82. PubMed ID: 22252870
[TBL] [Abstract][Full Text] [Related]
10. Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis.
Gupta A; Narayan B; Kumar S; Verma SK
Front Immunol; 2020; 11():988. PubMed ID: 32595634
[TBL] [Abstract][Full Text] [Related]
11. Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.
Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
Vaccine; 2008 Nov; 26(50):6329-37. PubMed ID: 18832004
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
Wang S; Goguen JD; Li F; Lu S
Vaccine; 2011 Sep; 29(39):6802-9. PubMed ID: 21199697
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.
Brewoo JN; Powell TD; Stinchcomb DT; Osorio JE
Vaccine; 2010 Aug; 28(36):5891-9. PubMed ID: 20638759
[TBL] [Abstract][Full Text] [Related]
14. A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.
Wang S; Heilman D; Liu F; Giehl T; Joshi S; Huang X; Chou TH; Goguen J; Lu S
Vaccine; 2004 Sep; 22(25-26):3348-57. PubMed ID: 15308359
[TBL] [Abstract][Full Text] [Related]
15. Different strategies for preparation of non-tagged rV270 protein and its efficacy against Yersinia pestis challenge.
Wang W; Qi ZZ; Zhang QW; Wu BC; Zhu ZW; Yang YH; Cui BZ; Dai RX; Qiu YF; Wang ZY; Guo ZB; Shi TX; Wang H; Yang RF; Wang XY
Biomed Environ Sci; 2010 Oct; 23(5):333-40. PubMed ID: 21112480
[TBL] [Abstract][Full Text] [Related]
16. Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.
Bhattacharya D; Mecsas J; Hu LT
Vaccine; 2010 Nov; 28(48):7683-9. PubMed ID: 20875494
[TBL] [Abstract][Full Text] [Related]
17. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
[TBL] [Abstract][Full Text] [Related]
18. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.
Chichester JA; Musiychuk K; Farrance CE; Mett V; Lyons J; Mett V; Yusibov V
Vaccine; 2009 May; 27(25-26):3471-4. PubMed ID: 19200825
[TBL] [Abstract][Full Text] [Related]
19. HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.
Batra L; Verma SK; Nagar DP; Saxena N; Pathak P; Pant SC; Tuteja U
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3322. PubMed ID: 25474358
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O
Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
